#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis chronic Congenital generalised lipodystrophy Osteopetrosis Neuromyelitis optica spectrum disorder Arteriosclerosis Hypersensitivity pneumonitis Progressive supranuclear palsy Follicle centre lymphoma follicular grade I, II – III Inborn error of metabolism Lymphatic malformation Salivary gland cancer Alpha-1 antitrypsin deficiency Leber's congenital amaurosis Ocular lymphoma Homocystinuria More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Trials in Disease Mucopolysaccharidosis II – Trials in Disease VEXAS syndrome – Trials in Disease Lennox-Gastaut syndrome – Diagnostics SAPHO syndrome – Trials in Disease Ewing’s sarcoma metastatic – Treatment Hairy cell leukaemia – Diagnostics Angiosarcoma non-metastatic – Diagnostics Optic glioma – Trials in Disease Adrenocortical carcinoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VTX-002 Daratumumab [89ZR]ZR-DFO-CIT-013 Oregovomab Technetium (99Mtc) Azd5492 MB-001 Xp-Dc+Tl+Klh Soya Oil YL201 Digitoxin Simeticone Ciprofloxacin Gs-5718-03 Eliglustat Tartrate Ion440 Sodium Hypochlorite ZIMISLECEL Mk-1942 Olodaterol More therapies…

    Learn about Your Condition

    Synovial sarcoma metastatic Follicular lymphoma stage III Bone marrow disorder Sickle cell anaemia Crigler-Najjar syndrome Fungal infection HER2 positive breast cancer Metastasis Thrombectomy Post procedural infection Mucous membrane pemphigoid Drug dependence Toxic nodular goitre Eosinophilic oesophagitis Metastases to peritoneum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study Comparing Abatacept and Tocilizumab for Adults with Rheumatoid Arthritis Not Responding to Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abatacept
    • Tocilizumab
    France

  • Study on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Delandistrogene Moxeparvovec
    Belgium France Germany Italy Spain

  • Study on the Effectiveness and Safety of Losmapimod for Patients with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Losmapimod
    Denmark France Germany Italy The Netherlands Spain

  • Study on AOC 1001 for Treating Myotonic Dystrophy Type 1 in Patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dmpk Via A Non-Cleavable Linker
    Denmark France Germany Ireland Italy The Netherlands +1

  • Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic inflammatory myopathy
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13

  • Study on the Safety and Effectiveness of Adalimumab and Etanercept in Children with Active Juvenile Idiopathic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Adalimumab
    • Etanercept
    Italy
Previous Page
1 … 44 45 46 47 48 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!